Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study
- PMID: 30624147
- DOI: 10.1080/10428194.2018.1533130
Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources